This article has been updated to include market reaction to the filing.

NEW YORK (GenomeWeb News) – Shares of Luminex fell nearly 10 percent today after the firm announced yesterday that it had filed a preliminary prospectus with the US Securities and Exchange Commission to offer 3.5 million shares of common stock.

Luminex's shares dropped 9.5 percent to $20.29 in late Tuesday trade on the Nasdaq.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.